Direct answer
Antenatal pelvic-floor muscle training (PFMT) has clearer evidence for reducing the chance of urinary leakage in pregnant people who were continent when training began than for treating leakage that is already present. In a major Cochrane review, prevention programmes probably reduced reports of late-pregnancy leakage, while a clear treatment effect was not established for participants already leaking.
That does not mean treatment never helps an individual. It means the evidence supports different confidence for different starting populations. Existing leakage should be characterized as stress, urgency, mixed, or another pattern and assessed for infection, emptying problems, and pregnancy concerns before a programme is chosen. No study establishes one universal dose or guarantees continence.
Why the starting population changes the question
Prevention asks whether training lowers the chance that a symptom begins. Treatment asks whether training improves a symptom that already exists. A mixed study includes both groups and may not report them separately. These designs answer different questions even if all participants perform pelvic-floor exercises.
If previously continent participants develop leakage less often, that does not show that the same programme treats established leakage. People already leaking may have different symptom severity, bladder patterns, technique problems, tissue or nerve factors, and time available for treatment. Combining groups can make a headline more positive or less precise than the underlying results.
Readers should therefore ask: Were participants leaking at baseline? Was training antenatal or postnatal? Was the outcome prevention, treatment, or both? Was the programme supervised? How long did follow-up last? These details determine how closely a finding applies.
What the Cochrane review found
The 2020 Cochrane review included antenatal and postnatal trials for urinary and faecal incontinence. It separated prevention, treatment, and mixed populations where possible.
For pregnant participants who were continent when training began, antenatal PFMT probably reduced urinary leakage in late pregnancy. A smaller preventive effect was seen at three to six months postpartum. This supports risk reduction, not certainty that every participant remained continent.
For participants who already had urinary leakage during pregnancy, the review did not establish a clear treatment effect in late pregnancy or later postpartum. Evidence for broad programmes started after birth was also uncertain in several comparisons. Programmes, supervision, adherence, reporting, and study quality varied, and evidence beyond twelve months was limited.
The responsible summary is asymmetric: prevention evidence is reasonably supportive for a defined group; treatment evidence is uncertain. Saying simply “Kegels work in pregnancy” erases that distinction.
What is established and what remains uncertain
More established: PFMT is a structured process, not a single squeeze; previously continent pregnant participants may reduce their risk of leakage; correct contraction and repeated practice matter; pregnancy complications and symptoms require individualized guidance.
Uncertain: the best start week, dose, supervision format, or progression; whether one programme treats existing antenatal leakage; long-term effects beyond the studied follow-up; and how results differ across leakage subtypes and individual pregnancy contexts.
Not established: guaranteed prevention, a guaranteed cure, prevention of birth injury or prolapse, or one routine that is safe for all pregnancies.
Textbook synthesis in Bø and colleagues similarly warns that antenatal and postnatal use, prevention and treatment populations, programme content, and outcomes must remain separate. The book is a research source; the reader link below is the official publisher record, not the private research copy.
Existing leakage is not one diagnosis
Stress urinary leakage occurs with coughing, sneezing, lifting, running, or another pressure rise. Urgency leakage accompanies a sudden compelling urge. Mixed leakage combines both. Leakage can also occur with urinary retention, infection, mobility barriers, neurological conditions, or other bladder problems.
The International Consultation on Incontinence emphasizes characterizing urinary symptoms before treatment. During pregnancy, burning, blood, fever, back or side pain, weak flow, straining, or incomplete emptying should not be assumed to be pelvic-floor weakness.
Fluid leakage that might be amniotic fluid is a maternity concern, not urinary-incontinence self-testing. Contact maternity care if the source is uncertain.
What prevention-oriented PFMT can reasonably include
A prevention programme can teach a gentle close and inward lift, full release, normal breathing, repeated practice over time, and timing with relevant pressure events. It should adapt to comfort, ability, trimester, and maternity guidance. The outcome is reduced risk, not a promise that no leakage will occur.
NICE encourages PFMT during pregnancy and recommends that supervised programmes assess contraction and relaxation and tailor training to ability, discomfort, needs, and goals. Its examples for higher-risk groups should not be turned into universal start dates or doses.
A person who cannot identify the movement, bears down, has pain, or cannot release should receive technique support rather than more repetitions.
What treatment-oriented care may add
Treatment begins with the leakage pattern and its effect on daily life. A pelvic-health physiotherapist can assess contraction direction, strength, endurance, relaxation, and timing. The plan may include PFMT, task-specific coordination, bladder strategies, constipation management, and referral for medical assessment.
The uncertain pregnancy-treatment evidence does not justify doing nothing, nor does it justify overpromising. It supports shared decision-making: explain the limits, choose a plausible and safe plan, and review outcomes. If leakage does not improve, reassess the pattern and programme rather than assuming that effort or motivation was inadequate.
An app cannot substitute for supervision. PelvicEx can prepare and run timed cues, but it cannot feel direction, confirm release, test urine, or classify leakage.
Pregnancy safety boundaries
ACOG describes exercise as generally appropriate in uncomplicated pregnancy after evaluation, while medical or obstetric complications require individual advice. Follow restrictions from the maternity team.
Stop and contact maternity care for vaginal bleeding, fluid leakage, regular painful contractions, dizziness or faintness, chest pain, marked breathlessness before exercise, calf pain or swelling, or other warning signs given by your team. Stop PFMT for pain, increasing pressure, bearing down, or inability to release.
Seek assessment for persistent or worsening leakage, urinary pain, blood, fever, weak flow, incomplete emptying, or a new pelvic bulge. Sudden inability to urinate is urgent.
How to read claims about pregnancy Kegels
Be cautious when a claim does not say whether it concerns prevention or treatment, who was studied, or when training began. Relative improvements can sound large without showing baseline risk. A positive average does not predict an individual outcome. Lack of evidence for a treatment effect is not proof of harm or impossibility, but it lowers confidence.
PelvicEx should describe this uncertainty openly. It should not convert a prevention result into a treatment marketing claim or use pregnancy to encourage excessive daily training.
Why supervision may change applicability
Some trials included instruction, feedback, or contact that a self-guided reader does not receive. That support can affect movement accuracy, adherence, adaptation, and reporting. A programme name alone does not show that app-based or unsupervised use is equivalent to the studied intervention.
When translating evidence into care, identify which components can be reproduced and which require examination or body-based feedback. PelvicEx can reproduce timed cues but cannot provide the assessment or feedback of a supervised programme. Any benefit claim must therefore remain tied to PFMT as studied, not transferred automatically to the product.
What would increase confidence
Confidence in treatment would improve with well-conducted trials that enroll participants already leaking, classify leakage patterns, report contraction instruction and adherence, compare a defined programme with appropriate care, record adverse effects, and follow outcomes beyond the immediate postpartum period. Until then, treatment should be presented as a reasonable individualized option with uncertain average effect, not as a proven pregnancy cure.
This page summarizes population evidence, not an individual prescription. PelvicEx cannot diagnose the leakage type or determine pregnancy safety. Maternity and clinician instructions take priority, and symptoms should guide review rather than a fixed completion target.
Evidence should guide language as well as decisions
Use “probably reduces risk” for the defined prevention population and “treatment effect remains uncertain” for existing leakage. Avoid “prevents,” “fixes,” and “clinically proven for pregnancy” without qualification. Clear language protects readers from treating an average study result as personal clearance or a guaranteed outcome.
Future studies may change certainty, but current publishing should use the evidence available now and display the review date. Updating a conclusion later is responsible evidence practice, not inconsistency.
Sources
- Woodley SJ et al. “Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women.” Cochrane Database of Systematic Reviews. 2020;CD007471. Cochrane evidence summary.
- Bø K, Berghmans B, Mørkved S, Van Kampen M, editors. Evidence-Based Physical Therapy for the Pelvic Floor. 3rd edition. Elsevier; 2023. Chapter 7. Official publisher record.
- National Institute for Health and Care Excellence. Pelvic floor dysfunction: prevention and non-surgical management. NG210. Recommendations.
- Cardozo L, Rovner E, Wagg A, Wein A, Abrams P, editors. Incontinence. 7th edition. International Consultation on Incontinence and International Continence Society; 2023. Chapter 4A. Official ICS edition.
- American College of Obstetricians and Gynecologists. “Physical Activity and Exercise During Pregnancy and the Postpartum Period.” Committee Opinion No. 804. Official guidance.